Astra's first-quarter device sales up 23%:
This article was originally published in Clinica
Astra (Sweden) has reported medical device sales growth of 23% to SKr 153 million ($21 million) for the first quarter of 1995 (ended March 31st). Overall turnover increased 35% to SKr 8,647 million, with net profits up 59% to SKr 2,236 million.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.